Sahu
According to UnivDatos analysis, rising prevalence of liver cancer, uterine fibroids, and vascular disorders, technological advancements in embolic agents, and growing FDA approvals are the major factors driving the growth of the embolotherapy market. As per their “Embolotherapy Market” report, the global market was valued at USD 4,084.29 million in 2024, growing at a CAGR of about 8.1% during the forecast period from 2025 – 2033 to reach USD million by 2033.
Embolotherapy is an intervention method in medicine that involves purposefully blocking blood vessels to treat a number of conditions, with the majority being cancers, vascular malformations, and uncontrollable bleeding. It is performed by interventional radiologists under imaging guidance and involves the injection of embolic agents (microspheres, coils, plugs, or liquid) into a target site so as to limit blood flow. It may reduce or kill tumors by decreasing blood flow to the tumor, preventing bleeding, or slowing blood flow prior to surgery. Embolotherapy has the advantage of a shorter recovery period, less surgical risk, and preservation of organs, which makes embolotherapy a choice over the conventional open surgical procedures.
Shift toward drug-eluting and radioembolization therapies
The transition to drug-eluting and radioembolization therapies is a significant trend in the embolotherapy market, driven by the fact that these therapies offer targeted treatments with higher efficacy and fewer side effects. Drug-eluting beads are capable of releasing chemotherapeutic agents at the site of the tumor and also block blood flow, thereby increasing local drug concentration and reducing systemic toxicity. Similarly, radioembolization introduces radioactive microspheres, such as Yttrium-90, into the tumor to irradiate it internally with high accuracy. Additionally, these methods are also useful in the treatment of liver tumors and metastatic tumors, improving the patient’s prognosis and reducing the recovery period. This therapeutic transition is being accelerated by growing clinical evidence, technological advancements, and increasing adoption by physicians.
Access sample report (including graphs, charts, and figures) – https://univdatos.com/reports/embolotherapy-market?popup=report-enquiry
Investments in Research and Development activities are driving the Growth in the Global Embolotherapy Market
The embolotherapy market is being fueled by investments in research and development, which has resulted in the development of better embolic agents, novel delivery methods and superior imaging technologies which have further contributed to increased treatment accuracy and safety. Bioresorbable microspheres, image-visible embolic, and combination therapies, including image-guided drug-eluting and radioembolization solutions, are some of the innovations developed from extensive R&D. Moreover, clinical trials and joint ventures between medical device developers, research centers, and healthcare providers accelerate product approval and market penetration, leading to strong market growth.
Related Reports –
Cerebral Embolic Protection Devices Market
Therapeutic Plasma Exchange Market
For instance, in January 2024, Merit Medical Systems initiated a multicenter, prospective, randomized controlled clinical trial named MOTION to evaluate the safety and effectiveness of Embosphere microspheres for genicular artery embolization (GAE) in patients with symptomatic knee osteoarthritis.
Rising Disease Burden and Innovation Fueling Market Expansion
The embolotherapy market is being driven by emerging trends, such as the shift towards drug-eluting and radioembolization therapies, as well as increasing investments in research and development activities. Such developments enhance the accuracy of the treatment procedure, increase its clinical use, and improve patient outcomes, ultimately leading to further adoption worldwide.
Contact Us:
Email – contact@univdatos.com
Website – www.univdatos.com
rasoi msterdam
Kevin Hill
